Lv1
48 积分 2021-12-13 加入
PARP14 as a master regulator of immune signaling and tumor microenvironment remodeling
2天前
已完结
Abstract P4-03-18: Chimerizing the HER2 receptor for functional and immunologic studies with αHER2 antibody-drug conjugates
4天前
求助中
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
7天前
已完结
Pregnenolone promotes immune evasion through blocking endogenous retrovirus expression
15天前
已完结
Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions
21天前
已完结
AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies
24天前
已完结
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
24天前
已完结
Data from Immune Reprogramming of Tumor Microenvironments by Cytotoxic Antibody–Drug Conjugate Payloads
1个月前
已关闭
Regulatory evolution of innate immunity through co-option of endogenous retroviruses
2个月前
已完结
Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance
2个月前
已完结
皖公网安备34019202002308
